⌘K
t
Tristel plc held its Annual General Meeting on December 16, 2024, where all resolutions were duly passed. The company confirmed that initial long-term incentive plan awards under Resolution 6 will be 50% based on EPS targets for FY 26/27 (0% vesting below 18p, 100% at 25p or better) and 50% based on relative total shareholder return over 3 years (0% vesting below median, 100% at upper quartile or above).
| Date | 16 Dec 2024 |
| Time | 14:45:59 |
| Category | AGMs and other meetings |
| ID | 2739Q |
TRISTEL plc
("Tristel" or the "Company")
Result of AGM
Tristel plc (AIM: TSTL), the manufacturer of infection prevention products, announces that at the Annual General Meeting held earlier today, all resolutions were duly passed.
The results of the AGM will be made available on the Company's website: https://investors.tristel.com/investor-hub/
The Company confirms that in relation to Resolution 6, the performance targets for the initial long-term incentive plan (LTIP) awards will be 50% based on earning per share (EPS) targets and 50% based on relative total shareholder return (TSR) versus the constituents of the AIM 100 as at the grant of the awards as follows:
|
50% of Initial awards |
50% of Initial awards |
|||
|
EPS FY 26/27 |
% of EPS Part that Vests |
Relative TSR measured over 3 years from grant |
% of TSR Part that Vests |
|
|
Less than 18p |
0% |
Below median |
0% |
|
|
Between 18p and 25p |
Pro-rata 25% to 100% |
Between median and upper quartile |
Pro-rata 25% to 100% |
|
|
25p or better |
100% |
Upper quartile or above |
100% |
|
For further information please contact:
|
Tristel plc |
Via Walbrook PR |
||
|
Matt Sassone, Chief Executive Officer |
|||
|
Liz Dixon, Chief Financial Officer |
|
||
|
|
|
||
|
Walbrook PR Ltd |
Tel: 020 7933 8780 or [email protected] |
||
|
Paul McManus / Lianne Applegarth / Alice Woodings |
Mob: 07980 541 893/ 07584 391 303/ 07407 804 654 |
||
|
|
|
||
|
Cavendish Capital Markets Ltd |
Tel: 020 7220 0500 |
||
|
Geoff Nash / Camilla Hume / Trisyia Jamaludin (Corporate Finance) |
|
||
|
Sunila de Silva (ECM) / Louise Talbot (Sales) |
|
||
About Tristel plc
Tristel plc is a global infection prevention company focussed on the manufacture and supply of products using its unique proprietary chlorine dioxide (ClO2) chemistry. The Company is a market leader in manual decontamination of medical devices, supplying hospitals under the Tristel brand, and under the Cache brand provides products for sporicidal surface disinfection, a more sustainable alternative to commonly used pre-wetted plastic wipes.
Tristel's head office and manufacturing facility is located in Snailwell, near Cambridge, and operates globally employing approximately 270 people across 16 subsidiaries selling into 40+ countries. The Company targets annual revenue growth of between 10% and 15% and an EBITDA margin of at least 25% and the business is profitable, with no debt and has a progressive dividend policy.
The Company has been listed on the London Stock Exchange's AIM market since 2005 (AIM: TSTL).
For more information about Tristel's product range please visit: https://tristel.com